Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00253643 · ClinicalTrials.gov registry record · NA
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
A NA study, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT00253643 is a NA study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 89 participants.
The verdict
NCT00253643, a NA study, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of fish oil and/or green tea may prevent prostate cancer. PURPOSE: This randomized clinical trial is studying how well a fish oil and/or green tea supplement works in preventing prostate cancer in patients with prostatic intraepithelial neoplasia or who are at risk for developing prostate cancer.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT fish oil
- DIETARY_SUPPLEMENT green tea catechin extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2005-07 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00253643
The ClinicalTrials.gov registry entry for NCT00253643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00253643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00253643 about?
NCT00253643 is a clinical study titled "Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer". RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of fish oil and/or green tea may prevent prostate cancer. PURPOSE: This randomized clinical trial is studying how well a fish oil and/or green tea supplement works in preventing pros...
What is the current status of trial NCT00253643?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2005-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00253643?
The interventions under investigation include: placebo (OTHER), fish oil (DIETARY_SUPPLEMENT), green tea catechin extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00253643?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.